Expression of ATP/GTP Binding Protein 1 Has Prognostic Value for the Clinical Outcomes in Non-Small Cell Lung Carcinoma

被引:3
|
作者
Kwak, Hee Jeong [1 ]
Gil, Minchan [1 ]
Chae, Hee Sung [1 ]
Seok, Jaekwon [1 ]
Soundrarajan, Nagasundarapandian [1 ]
Saha, Subbroto Kumar [1 ]
Kim, Aram [2 ]
Park, Kyoung Sik [3 ]
Park, Chankyu [1 ]
Cho, Ssang-Goo [1 ]
机构
[1] Konkuk Univ, Incurable Dis Anim Model & Stem Cell Inst IDASI, Dept Stem Cell & Regenerat Biotechnol, 120 Neungdong Ro, Seoul 05029, South Korea
[2] Konkuk Univ, Med Ctr, Sch Med, Dept Urol, Seoul 05029, South Korea
[3] Konkuk Univ, Sch Med, Med Ctr, Dept Surg, Seoul 05029, South Korea
来源
JOURNAL OF PERSONALIZED MEDICINE | 2020年 / 10卷 / 04期
关键词
AGTPBP1; lung cancer; expression level; prognosis; patient survival; TUBULIN TYROSINE LIGASE; MICROTUBULE DYNAMICS; GENE-EXPRESSION; ALPHA-TUBULIN; BETA-TUBULIN; CANCER CELLS; WEB SERVER; DOXORUBICIN; APOPTOSIS; PATHWAY;
D O I
10.3390/jpm10040263
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
ATP/GTP binding protein 1 (AGTPBP1) encodes a crucial protein, cytosolic carboxypeptidase 1 (CCP1), which plays a role in modulating the polyglutamylation of tubulin and has been studied in degenerative diseases. However, the role of AGTPBP1 in malignancy has not been completely studied yet. In this study, we examined the role of AGTPBP1 in cancer progression, its association with patient survival, and related mechanisms in lung cancer, using the A549 cell line and lung cancer gene expression datasets. AGTPBP1 knockdown increased the proliferation, migration, sphere formation, and drug resistance of A549 cells. Lung cancer datasets revealed significantly lower mRNA and protein expression levels of AGTPBP1 in lung cancer tissues, as compared to those in normal tissues. Importantly, AGTPBP1 expression positively correlated with patient survival. Analysis of co-expressed genes revealed that AGTPBP1 expression positively correlated with immune infiltration in lung cancer. Our results conclusively suggested that AGTPBP1 expression was correlated with cancer progression and immune infiltration in lung cancer.
引用
收藏
页码:1 / 22
页数:22
相关论文
共 50 条
  • [31] Prognostic and predictive biomarkers in non-small cell lung carcinoma
    Odintsov, Igor
    Sholl, Lynette m.
    PATHOLOGY, 2024, 56 (02) : 192 - 204
  • [32] The small GTPase RhoA has greater expression in small cell lung carcinoma than in non-small cell lung carcinoma and contributes to their unique morphologies
    Varker, KA
    Phelps, SH
    King, MM
    Williams, CL
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2003, 22 (03) : 671 - 681
  • [33] The Prognostic Impact of BRCA1 Protein Expression in Patients With Non-small Cell Lung Cancer
    Gachechiladze, M.
    Skarda, J.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S184 - S184
  • [34] Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients
    Fan, Jinping
    Yu, Haiying
    Lv, Ying
    Yin, Liguo
    TUMOR BIOLOGY, 2016, 37 (02) : 1949 - 1958
  • [35] Prognostic value of thyroid transcription factor-1 in primary, resected, non-small cell lung carcinoma
    Puglisi, F
    Barbone, F
    Damante, G
    Bruckbauer, M
    Di Lauro, V
    Beltrami, CA
    Di Loreto, C
    MODERN PATHOLOGY, 1999, 12 (03) : 318 - 324
  • [36] MicroRNA-155 Expression has Prognostic Value in Patients with Non-small Cell Lung Cancer and Digestive System Carcinomas
    Xu, Tong-Peng
    Zhu, Can-Hong
    Zhang, Jian
    Xia, Rui
    Wu, Feng-Lei
    Han, Liang
    Shen, Hua
    Liu, Ling-Xiang
    Shu, Yong-Qian
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (12) : 7085 - 7090
  • [37] Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases
    Moldvay, Judit
    Fabian, Katalin
    Jackel, Marta
    Nemeth, Zsuzsanna
    Bogos, Krisztina
    Furak, Jozsef
    Tiszlavicz, Laszlo
    Fillinger, Janos
    Dome, Balazs
    Schaff, Zsuzsa
    PATHOLOGY & ONCOLOGY RESEARCH, 2017, 23 (01) : 151 - 156
  • [38] Postoperative Radiotherapy for Incompletely Resected Non-small Cell Lung Cancer: Clinical Outcomes and Prognostic Value of the Histological Subtype
    Ohguri, Takayuki
    Yahara, Katsuya
    Moon, Seung Dae
    Yamaguchi, Shinsaku
    Imada, Hajime
    Hanagiri, Takeshi
    Tanaka, Fumihiro
    Terashima, Hiromi
    Korogi, Yukunori
    JOURNAL OF RADIATION RESEARCH, 2012, 53 (02) : 319 - 325
  • [39] The prognostic value of intraepithelial and stromal innate immune cells in non-small cell lung carcinoma
    Al-Shibli, K.
    Al-Saad, S.
    Donnem, T.
    Persson, M.
    Bremnes, R.
    Busund, L.
    HISTOPATHOLOGY, 2008, 53 : 337 - 337
  • [40] Prognostic value of FHIT, CTNNB1, and MUC1 expression in non-small cell lung cancer
    Woenckhaus, Matthias
    Merk, Johannes
    Stoehr, Robert
    Schaeper, Frank
    Gaumann, Andreas
    Wiebe, Karsten
    Hartmann, Arndt
    Hofstaedter, Ferdinand
    Dietmaier, Wolfgang
    HUMAN PATHOLOGY, 2008, 39 (01) : 126 - 136